Novo Nordisk is pursuing legal proceedings against two compounding pharmacies for selling adulterated and misbranded compounded drugs claiming to contain semaglutide," the company said in a statement
Using real-world data The study has been published in Nature Health and investigated data from 410,198 Reddit posts by 67,008 users, between May 2019 and June 2025
Rybelsus acts as a GLP-1 receptor agonist that suppresses appetite, reduces food cravings, and delays gastric emptying helping individuals feel fuller longer and naturally consume fewer calories
GLP-1s stimulate insulin secretion, reduce glucose production in the liver, and slow stomach motility to help regulate blood sugar levels after and in between meals
Based on major clinical trials, patients typically achieve an average weight reduction of 15% to 20% of their initial body weight when the medication is consistently combined with a comprehensive lifestyle program